Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice-Reference-Cited by-同舟云学术

Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice

Published:2021-11 Issue: Volume:126 Page:105029
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Namdari Rostam,Jones Keith,Chuang Samuel S.,Van Cruchten Steven^ORCID,Dincer Zuhal,Downes Noel,Mikkelsen Lars Friis,Harding Joanna,Jäckel Sven^ORCID,Jacobsen Björn^ORCID,Kinyamu-Akunda Jacqueline,Lortie Andréanne,Mhedhbi Sofiene^ORCID,Mohr Susanne,Schmitt Michael W.,Prior Helen^ORCID

Funder

Roche

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference24 articles.

1. 2010/63/Eu, Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes.

2. Group housing of male CD1 mice: reflections from toxicity studies;Annas;Lab. Anim,2013

3. Getting a molecule into the clinic: nonclinical testing and starting dose considerations;Baldrick;Regul. Toxicol. Pharmacol.,2017

4. Nonclinical & clinical interface - extrapolation of nonclinical data to support Phase I clinical studies;Baldrick;Regul. Toxicol. Pharmacol.,2021

5. Current strategies in the non-clinical safety assessment of biologics: new targets, new molecules, new challenges;Brennan;Regul. Toxicol. Pharmacol.,2018

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of a new drug based on polysaccharide from acorus calamus in an experiment on laboratory animals;Drug development & registration;2024-09-13

2. Exemplifying interspecies variation of liposome in vivo fate by the effects of anti-PEG antibodies;Acta Pharmaceutica Sinica B;2024-08

3. Safety Implications of Modulating Nuclear Receptors: A Comprehensive Analysis from Non-Clinical and Clinical Perspectives;Pharmaceuticals;2024-07-03

4. Maximizing insights from nonclinical safety studies in the context of rising costs and changing regulations;Journal of Pharmacological and Toxicological Methods;2024-07

5. Innovative approaches to cardiovascular safety pharmacology assessment;Journal of Pharmacological and Toxicological Methods;2024-07